This compound is a halogenated pentofuranose derivative featuring two 4-chlorobenzoyl ester groups and a bromine atom at the anomeric position. It is primarily used as a pharmaceutical intermediate in the synthesis of complex organic molecules.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1294481-81-4
9-[(2R)-3,5-Bis-O-(4-chlorobenzoyl)-2-deoxy-2-fluoro-2-methyl-beta-D-erythro-pentofuranosyl]-6-chloro-9H-purin-2-amine
pharmaceutical intermediate
(2R)-1-{5-Amino-2-[1-(benzyloxy)-2-methyl-2-propanyl]-6-fluoro-1H-indol-1-yl}-3-(benzyloxy)-2-propanol
pharmaceutical intermediate
Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
pharmaceutical intermediate
3-(1,1-difluoroallyl)quinoxalin-2(1H)-one
pharmaceutical intermediate
1-Chloro-3,5-di(4-chlorbenzoyl)-2-deoxy-D-ribose
pharmaceutical intermediate
2-Deoxy-alpha-D-erythropentofuranose 1-acetate 3,5-bis(4-chlorobenzoate)
pharmaceutical intermediate
2-Deoxy-2,2-difluoro-alpha-D-erythro-pentofuranose 3,5-dibenzoate 1-methanesulfonate
pharmaceutical intermediate
1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose
pharmaceutical intermediate
[(2R,3R,4R,5R)-5-bromo-3-(4-chlorobenzoyl)oxy-4-fluoro-4-methyloxolan-2-yl]methyl 4-chlorobenzoate
ODHZHAXYYVTQQB-YAJHFMINSA-N
C[C@]1([C@@H]([C@H](O[C@@H]1Br)COC(=O)C2=CC=C(C=C2)Cl)OC(=O)C3=CC=C(C=C3)Cl)F
—